Spironolactone
- Product NDC
- 43063-802
- 11-digit product format
- 430630802
- Labeler code
- 43063
- Product ID
- 43063-802_aa7ff080-3fde-234a-e053-2a95a90ad261
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- spironolactone
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA040750
- Marketing category
- ANDA
- Marketing start
- 2006-08-29
- Marketing end
- 2021-07-31
- Substance
- SPIRONOLACTONE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43063-802-30 | 43063080230 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-802-30) | 2017-11-02 | 2021-07-31 | No | No | Current |
| 43063-802-90 | 43063080290 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-802-90) | 2017-11-02 | 2021-07-31 | No | No | Current |